Challenges for epigenetic research in inflammatory bowel diseases

Area of Science:

• Epigenetics and Immunology
• Gastroenterology
• Microbiome Research

Background:

• Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn disease (CD), are complex conditions influenced by genetic and environmental factors.
• The developmental origins of IBD involve interactions between genetic predisposition, early-life environmental exposures, and gut microbiota dysbiosis.
• Immune dysregulation is a critical component in the development, progression, and maintenance of IBD.

Purpose of the Study:

• To review the role of the human epigenome in linking environmental exposures and microbiota changes to IBD pathogenesis.
• To highlight the challenges and opportunities in epigenetic research for IBD.
• To estimate the prevalence of genetic and epigenetic susceptibility to UC and CD.

Main Methods:

• Literature review focusing on epigenetic mechanisms in IBD.
• Analysis of factors contributing to IBD development, including genetics, environment, and microbiome.
• Prevalence estimation based on genetic and epigenetic susceptibility.

Main Results:

• The human epigenome serves as a potential mediator between environmental factors, microbiota, and IBD development.
• Genetic and epigenetic susceptibility to UC and CD is estimated at 2% combined, with approximately 1% for each disease in developed countries.
• Significant challenges exist in conducting epigenetic research for IBD.

Conclusions:

• Epigenetic research in IBD holds promise for identifying novel strategies for disease prevention, treatment, and potentially a cure.
• Overcoming current research challenges could unlock significant opportunities in managing inflammatory bowel diseases.
• A deeper understanding of epigenetic modifications is crucial for unraveling the complex etiology of UC and CD.